文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

产前类固醇与早产儿视网膜病变风险的关联:系统综述与Meta分析

Association of antenatal steroid and risk of retinopathy of prematurity: a systematic review and meta-analysis.
PubMed 文献 · Br J Ophthalmol · 2018-04-09

该系统综述与Meta分析检索MEDLINE和Embase自建库至2016年11月的文献,纳入28项研究、20731例新生儿(其中4202例发生早产儿视网膜病变(ROP)),评估产前类固醇使用与ROP及其进展为严重ROP的关联。结果显示,产前类固醇使用与ROP发生风险降低及进展为严重ROP风险降低相关。

要点

  • 产前类固醇使用与ROP发生风险降低相关(未校正OR=0.82,95%CI 0.68至0.98;校正OR=0.67,95%CI 0.47至0.94)。
  • 产前类固醇使用与进展为严重ROP风险降低相关(未校正OR=0.58,95%CI 0.40至0.86)。
  • 28项研究中13项评估严重ROP,涉及4999例新生儿、792例严重ROP病例。

核心结论

  • 产前类固醇使用与ROP发生风险降低及进展为严重ROP风险降低相关。
  • 作者认为结果强化了产前类固醇治疗用于高危早产母亲的指征,尤其在产前类固醇尚未广泛使用的低收入和中等收入国家。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE和Embase自建库至2016年11月的报告研究。
  • 共识别434项相关研究,28项纳入Meta分析,涉及20731例新生儿、4202例ROP病例。
  • 28项研究中13项提供产前类固醇使用与严重ROP关联的数据,涉及4999例新生儿、792例严重ROP病例。
  • 结局指标为OR及其95%CI,酌情采用随机效应模型或固定效应模型合并数据,并进行异质性评估和敏感性分析。

主要发现

  • 产前类固醇使用与ROP发生风险降低相关:未校正OR=0.82(95%CI 0.68至0.98),校正OR=0.67(95%CI 0.47至0.94)。
  • 产前类固醇使用与进展为严重ROP风险降低相关:未校正OR=0.58(95%CI 0.40至0.86)。

临床怎么用

  • 作者认为结果强化了产前类固醇治疗用于高危早产母亲的指征,尤其在产前类固醇尚未广泛使用的低收入和中等收入国家。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Retinopathy of prematurity (ROP) is one of the leading causes of childhood blindness. Use of antenatal steroid can reduce neonatal morbidity and mortality in preterm births, but its effect on ROP remained controversial. We aim to determine the association between antenatal steroid and risk of ROP by a systematic review and meta-analysis. METHODS: Reported studies on the association between antenatal steroid and risk of ROP or severe ROP were identified from MEDLINE and Embase databases from their inception to November 2016. Outcome measures were ORs with 95% CIs. Extracted data were pooled using a random-effect model or fixed-effect model where appropriate. Heterogeneity was assessed, and sensitivity analysis was performed. RESULTS: A total of 434 relevant studies were identified, and 28 studies were eligible for the meta-analysis, involving 20 731 neonates with 4202 cases of ROP. Among the 28 studies included, 13 studies provided data evaluating the association between antenatal steroid use and severe ROP, involving 4999 neonates with 792 cases of severe ROP. Antenatal steroid administration was associated with a reduced risk of ROP development (ORunadjusted=0.82, 95% CI 0.68 to 0.98; ORadjusted=0.67, 95% CI 0.47 to 0.94) and progression to severe ROP (ORunadjusted=0.58, 95% CI 0.40 to 0.86). CONCLUSION: Antenatal steroid administration is associated with a reduced risk of ROP development and progression to severe ROP. Our results strengthened the indications of antenatal steroid therapy to high-risk mothers giving preterm births, especially in low-income and middle-income countries where antenatal steroid are not yet widely used.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Yim CL, Tam M, Chan HL, et al. Association of antenatal steroid and risk of retinopathy of prematurity: a systematic review and meta-analysis. Br J Ophthalmol. 2018. PMID: 29632000. doi:10.1136/bjophthalmol-2017-311576

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。